NeuroPace (NPCE) Accumulated Expenses (2020 - 2026)

NeuroPace's Accumulated Expenses history runs 7 years deep, the most recent figure standing at $9.3 million for Q1 2026.

• On a quarterly basis, Accumulated Expenses rose 15.96% year-over-year to $9.3 million in Q1 2026; TTM through Mar 2026 was $9.3 million, a 15.96% increase from a year earlier, with the FY2025 full-year figure at $13.3 million, up 36.29% from the prior year.
• Accumulated Expenses eased to $9.3 million in Q1 2026 per NPCE's latest filing, from $13.3 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $13.3 million in Q4 2025 and bottomed at $6.6 million in Q1 2023.
• The 5-year median for Accumulated Expenses is $8.2 million (2023), against an average of $9.0 million.
• Across the five-year window, Accumulated Expenses jumped 87.73% in 2022 and dropped 12.46% in 2024, its largest moves.
• Year by year, Accumulated Expenses stood at $7.4 million in 2022, then surged by 50.8% to $11.2 million in 2023, then dropped by 12.46% to $9.8 million in 2024, then soared by 36.29% to $13.3 million in 2025, then declined by 29.95% to $9.3 million in 2026.
• Per Business Quant, the three latest NPCE Accumulated Expenses figures stand at $9.3 million (Q1 2026), $13.3 million (Q4 2025), and $12.3 million (Q3 2025).